<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>S2 E1 - Arvind Dasari, MD MS – Emerging Treatments in Colorectal Cancer</title>
  <description> This is the first episode in our series on colorectal cancer which aims to update clinicians on the latest developments in treatment.  In this episode, Dr. Arvind Dasari starts by explaining the current management of colorectal cancer, and then outlines the latest developments in immunotherapy and targeted therapies, touching on specific trials presented at ASCO GI 2023. Trials discussed include Phase III SUNLIGHT, Phase III Fresco-2 and PARADIGM. For more podcast episodes from Karger please visit karger.com/pages/podcasts. This podcast was funded by&amp;amp;nbsp;Taiho&amp;amp;nbsp;Oncology, Inc.&amp;amp;nbsp; The faculty and publisher are solely responsible for this content.&amp;amp;nbsp;Taiho&amp;amp;nbsp;does not recommend or endorse&amp;amp;nbsp; the use of its products other than as described in the approved labeling. The content of this site is not medical advice and does not replace independent medical judgment. </description>
  <author_name>Karger - Fast Facts Oncology</author_name>
  <author_url>https://sites.libsyn.com/444057</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/27266496/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/154871952</thumbnail_url>
</oembed>
